Induction of antiviral factors by IFN-α 2a is time and dose dependent
Authors
Abstract:
Background and Aims: Interferon alpha is an effective cytokine in viral infections, where it has various roles in immune function. The use of this antiviral agent in the treatment of viral infections and even cancers is common, although, the beneficial effects of this antiviral agent in high doses can be associated with side effects that limit its use. In this project, we tried to investigate the effects of different doses and timing of interferon alpha treatment on the expression of downstream interferon signaling genes and evaluation of the antiviral effects in patients with chronic hepatitis C. Materials and Methods: Peripheral blood mononuclear cells (PBMCs) were isolated from treatment-naive HCV-infected patients. The cells were treated with different doses of Interferon alpha 2a (IFN-α 2a) and the mRNA expression of target genes (ISG15, MXA, PKR and OAS) at different time points was evaluated by Real Time PCR. The levels of ISG15 and OAS were measured in culture supernatant using ELISA and the level of HCV NS5A in chronic HCV patients was measured by flow cytometry. Results: Our results showed that IFN-α 2a effect on the expression of antiviral proteins was dependent on dose and time of administrated IFN-α. Conclusions: This finding indicates that IFN-α should be used at optimal dose to achieve the best efficiency and established balance between antiviral and anti-tumor effects of IFN-α with fewer side effects.
similar resources
Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients.
BACKGROUND & AIMS Danoprevir (RG7227; ITMN-191) is a potent inhibitor of the HCV NS3/4A serine protease. The aims of this double-blind, placebo-controlled, multiple-ascending dose phase Ib study were to evaluate safety, tolerability, antiviral activity, resistance, and pharmacokinetics of once- and twice-daily danoprevir in the presence of low-dose ritonavir (danoprevir/r) and in combination wi...
full textThe Effect of Heat Shock on Production of Recombinant Human Interferon Alpha 2a (rhIFN α -2a) by Escherichia coli
Recombinant human interferon alpha 2a (rhIFN α -2a) production and cell growth were monitored in a set of genetically modified E. coli strains (MSD1519, MSD1520, MSD 1521, MSD 1522, MSD 1523) producing rhIFN α -2a. The growth was followed at OD 600 nm, changes in cell physiology were detected by pyrolysis mass spectrometry (PyMS) of cell biomass and recombinant protein production was determined...
full textDose- and time-dependent micronucleus induction in peripheral erythrocytes of catfish, Heteropneustes fossilis (Bloch) by zinc
As far as the detection of metal genotoxicity in fish is concerned, micronucleus (MN) test is considered an extremely suitable measure. In this study, frequencies of micronucleated erythrocytes were scored in peripheral blood of catfish, Heteropneustes fossilis (bloch) after acute in-vivo exposure of zinc at different concentrations (5, 10 and 30 ppm) in the laboratory condition. These three co...
full textIFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction.
Viperin is an antiviral protein whose expression is highly upregulated during viral infections via IFN-dependent and/or IFN-independent pathways. We examined the molecular alterations induced by the transcriptional activator IFN regulatory factor (IRF)-1 and found viperin to be among the group of IRF-1 regulated genes. From these data, it was not possible to distinguish genes that are primary t...
full textBiological Dose Assessment by Chemical Induction of Premature Chromosome Condensation
Dose assessment of radiation victims is a key element in medical management of radiation accidents. At high radiation doses (> 6 Gy), dicentric assay lose its efficiency and premature chromosome condensation (PCC) assay was proposed to overcome the restrictions of dicentric assay. It was shown that PCC ring is more suitable and simpler than dicentric for biodosimetry in high radiation doses. In...
full textMy Resources
Journal title
volume 14 issue None
pages 0- 0
publication date 2020-12
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023